Guidant Will Distribute Thoratec's Vectra Vascular Access Graft Worldwide
This article was originally published in The Gray Sheet
Guidant is extending its vascular surgery product offerings, adding Thoratec Labs' Vectra access graft under an exclusive distribution agreement announced Jan. 14.
You may also be interested in...
China’s Bio-Thera Solutions has ventured outside of its domestic market for the first time by filing an application for a biosimilar version of Avastin with the European Medicines Agency. The company has also revealed its timeline for a submission to the FDA.
Recent and upcoming US FDA advisory committee meetings and a summary of topics covered.
Under EU rules, once a medicinal product has been placed on the market in a country of the EEA – the EU plus Iceland, Liechtenstein and Norway